166 related articles for article (PubMed ID: 28237650)
1. Inhibition and inactivation of human CYP2J2: Implications in cardiac pathophysiology and opportunities in cancer therapy.
Karkhanis A; Hong Y; Chan ECY
Biochem Pharmacol; 2017 Jul; 135():12-21. PubMed ID: 28237650
[TBL] [Abstract][Full Text] [Related]
2. Danazol Inhibits Cytochrome P450 2J2 Activity in a Substrate-independent Manner.
Lee E; Wu Z; Shon JC; Liu KH
Drug Metab Dispos; 2015 Aug; 43(8):1250-3. PubMed ID: 26048912
[TBL] [Abstract][Full Text] [Related]
3. Atypical kinetics of cytochrome P450 2J2: Epoxidation of arachidonic acid and reversible inhibition by xenobiotic inhibitors.
Leow JWH; Verma RK; Lim ABH; Fan H; Chan ECY
Eur J Pharm Sci; 2021 Sep; 164():105889. PubMed ID: 34044117
[TBL] [Abstract][Full Text] [Related]
4. Plant natural product plumbagin presents potent inhibitory effect on human cytochrome P450 2J2 enzyme.
Lu J; Liu D; Zhou X; Chen A; Jiang Z; Ye X; Liu M; Wang X
Phytomedicine; 2018 Jan; 39():137-145. PubMed ID: 29433675
[TBL] [Abstract][Full Text] [Related]
5. Identifying a selective substrate and inhibitor pair for the evaluation of CYP2J2 activity.
Lee CA; Jones JP; Katayama J; Kaspera R; Jiang Y; Freiwald S; Smith E; Walker GS; Totah RA
Drug Metab Dispos; 2012 May; 40(5):943-51. PubMed ID: 22328583
[TBL] [Abstract][Full Text] [Related]
6. Multiple modes of inhibition of human cytochrome P450 2J2 by dronedarone, amiodarone and their active metabolites.
Karkhanis A; Lam HY; Venkatesan G; Koh SK; Chai CL; Zhou L; Hong Y; Kojodjojo P; Chan EC
Biochem Pharmacol; 2016 May; 107():67-80. PubMed ID: 26972388
[TBL] [Abstract][Full Text] [Related]
7. Activity, inhibition, and induction of cytochrome P450 2J2 in adult human primary cardiomyocytes.
Evangelista EA; Kaspera R; Mokadam NA; Jones JP; Totah RA
Drug Metab Dispos; 2013 Dec; 41(12):2087-94. PubMed ID: 24021950
[TBL] [Abstract][Full Text] [Related]
8. Effects of dronedarone, amiodarone and their active metabolites on sequential metabolism of arachidonic acid to epoxyeicosatrienoic and dihydroxyeicosatrienoic acids.
Karkhanis A; Tram NDT; Chan ECY
Biochem Pharmacol; 2017 Dec; 146():188-198. PubMed ID: 28958841
[TBL] [Abstract][Full Text] [Related]
9. Selective inhibitors of CYP2J2 related to terfenadine exhibit strong activity against human cancers in vitro and in vivo.
Chen C; Li G; Liao W; Wu J; Liu L; Ma D; Zhou J; Elbekai RH; Edin ML; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2009 Jun; 329(3):908-18. PubMed ID: 19289568
[TBL] [Abstract][Full Text] [Related]
10. Cytochrome P450 2J2 is highly expressed in hematologic malignant diseases and promotes tumor cell growth.
Chen C; Wei X; Rao X; Wu J; Yang S; Chen F; Ma D; Zhou J; Dackor RT; Zeldin DC; Wang DW
J Pharmacol Exp Ther; 2011 Feb; 336(2):344-55. PubMed ID: 21030485
[TBL] [Abstract][Full Text] [Related]
11. Investigating the relevance of CYP2J2 inhibition for drugs known to cause intermediate to high risk torsades de pointes.
Leow JWH; Gu Y; Chan ECY
Eur J Pharm Sci; 2023 Aug; 187():106475. PubMed ID: 37225005
[TBL] [Abstract][Full Text] [Related]
12. Cytochrome P450 2J2: distribution, function, regulation, genetic polymorphisms and clinical significance.
Xu M; Ju W; Hao H; Wang G; Li P
Drug Metab Rev; 2013 Aug; 45(3):311-52. PubMed ID: 23865864
[TBL] [Abstract][Full Text] [Related]
13. [Research progress of human cytochrome P450 2J2 and its ligands].
Ma HY; Ning J; Ge GB; Yang L; Hao DC
Yao Xue Xue Bao; 2017 Jan; 52(1):26-33. PubMed ID: 29911373
[TBL] [Abstract][Full Text] [Related]
14. Molecular determinant of substrate binding and specificity of cytochrome P450 2J2.
Xu L; Chen LY
Sci Rep; 2020 Dec; 10(1):22267. PubMed ID: 33335233
[TBL] [Abstract][Full Text] [Related]
15. The roles of CYP450 epoxygenases and metabolites, epoxyeicosatrienoic acids, in cardiovascular and malignant diseases.
Xu X; Zhang XA; Wang DW
Adv Drug Deliv Rev; 2011 Jul; 63(8):597-609. PubMed ID: 21477627
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of Cytochrome P450 2J2-Mediated Metabolism of Rivaroxaban and Arachidonic Acid by Ibrutinib and Osimertinib.
Wang Z; Yong Chan EC
Drug Metab Dispos; 2022 Oct; 50(10):1332-1341. PubMed ID: 35817438
[TBL] [Abstract][Full Text] [Related]
17. CYP2J2-mediated metabolism of arachidonic acid in heart: A review of its kinetics, inhibition and role in heart rhythm control.
Leow JWH; Chan ECY
Pharmacol Ther; 2024 Jun; 258():108637. PubMed ID: 38521247
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory effects of antihypertensive drugs on human cytochrome P450 2J2 activity: Potent inhibition by azelnidipine and manidipine.
Ikemura N; Yamaori S; Kobayashi C; Kamijo S; Murayama N; Yamazaki H; Ohmori S
Chem Biol Interact; 2019 Jun; 306():1-9. PubMed ID: 30965050
[TBL] [Abstract][Full Text] [Related]
19. Potential of decursin to inhibit the human cytochrome P450 2J2 isoform.
Lee B; Wu Z; Sung SH; Lee T; Song KS; Lee MY; Liu KH
Food Chem Toxicol; 2014 Aug; 70():94-9. PubMed ID: 24788058
[TBL] [Abstract][Full Text] [Related]
20. Terfenadone is a strong inhibitor of CYP2J2 present in the human liver and intestinal microsomes.
Lee E; Kim JH; Shon JC; Wu Z; Kim HJ; Gim M; Lee T; Liu KH
Drug Metab Pharmacokinet; 2018 Jun; 33(3):159-163. PubMed ID: 29759885
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]